Next Article in Journal
New Insights into the Role of Neuron-Specific Enolase in Neuro-Inflammation, Neurodegeneration, and Neuroprotection
Next Article in Special Issue
Abstraction and Idealization in Biomedicine: The Nonautonomous Theory of Acute Cell Injury
Previous Article in Journal
With a Little Help from My Friends: The Role of Intraoperative Fluorescent Dyes in the Surgical Management of High-Grade Gliomas
Previous Article in Special Issue
Recurrent Hemorrhagic Conversion of Ischemic Stroke in a Patient with Mechanical Heart Valve: A Case Report and Literature Review
Open AccessReview

Neuroprotective Effects of Bioactive Compounds and MAPK Pathway Modulation in “Ischemia”—Stressed PC12 Pheochromocytoma Cells

1
School of Pharmacy, The Institute for Drug Research, The Hebrew University of Jerusalem, P.O. Box 12065, Jerusalem 9112102, Israel
2
Department of Neurobiology, The Weizmann Institute of Science, Rehovot 7610001, Israel
*
Author to whom correspondence should be addressed.
Brain Sci. 2018, 8(2), 32; https://doi.org/10.3390/brainsci8020032
Received: 14 December 2017 / Revised: 24 January 2018 / Accepted: 2 February 2018 / Published: 8 February 2018
This review surveys the efforts taken to investigate in vitro neuroprotective features of synthetic compounds and cell-released growth factors on PC12 clonal cell line temporarily deprived of oxygen and glucose followed by reoxygenation (OGD/R). These cells have been used previously to mimic some of the properties of in vivo brain ischemia-reperfusion-injury (IRI) and have been instrumental in identifying common mechanisms such as calcium overload, redox potential, lipid peroxidation and MAPKs modulation. In addition, they were useful for establishing the role of certain membrane penetrable cocktails of antioxidants as well as potential growth factors which may act in neuroprotection. Pharmacological mechanisms of neuroprotection addressing modulation of the MAPK cascade and increased redox potential by natural products, drugs and growth factors secreted by stem cells, in either undifferentiated or nerve growth factor-differentiated PC12 cells exposed to ischemic conditions are discussed for future prospects in neuroprotection studies. View Full-Text
Keywords: antioxidants; growth factors; ischemia; lipid peroxidation; MAP kinases; neuroprotection; NGF; oxygen-glucose deprivation and reoxygenation injury; PC12 pheochromocytoma cells; stem cells antioxidants; growth factors; ischemia; lipid peroxidation; MAP kinases; neuroprotection; NGF; oxygen-glucose deprivation and reoxygenation injury; PC12 pheochromocytoma cells; stem cells
Show Figures

Figure 1

MDPI and ACS Style

Lahiani, A.; Brand-Yavin, A.; Yavin, E.; Lazarovici, P. Neuroprotective Effects of Bioactive Compounds and MAPK Pathway Modulation in “Ischemia”—Stressed PC12 Pheochromocytoma Cells. Brain Sci. 2018, 8, 32.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop